Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device

Cardiac transplantation is a limited option for end-stage heart failure because of the shortage of donor organs. Left-ventricular assist devices (LVADs) are currently under investigation as permanent therapy for end-stage heart failure, but long-term successful device implantation is limited because...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1999-08, Vol.354 (9178), p.550-555
Hauptverfasser:	ANKERSMIT, H. J, TUGULEA, S, OZ, M. C, ITESCU, S, SPANIER, T, WEINBERG, A. D, ARTRIP, J. H, BURKE, E. M, FLANNERY, M, MANCINI, D, ROSE, E. A, EDWARDS, N. M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Apoptosis Biological and medical sciences Candidiasis - epidemiology Candidiasis - etiology Cell Death Cells Emergency and intensive respiratory care Female Flow Cytometry Heart Failure - complications Heart Failure - immunology Heart Failure - surgery Heart-Assist Devices - adverse effects Heart-Assist Devices - microbiology Humans Infections Intensive care medicine Lymphocyte Activation Lymphocytes Male Medical research Medical sciences Medical technology Middle Aged Mortality Risk Factors T-Lymphocytes - cytology T-Lymphocytes - immunology Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!